Menu
As a team with a rich antiviral heritage, we have undertaken expansive efforts to unravel SARS-CoV-2 biology and directed our discovery platform to identify and develop COVID-19 therapeutics.
Check back regularly for updates.
Our COVID-19 efforts and programs reside under
May 2020
We published the first high-resolution X-ray crystal structure of the mysterious ORF9B protein of SARS-CoV-2.
july 2020
We revealed that famotidine, being repurposed for COVID-19 treatment, does not target anti-SARS-CoV-2 replication.
Preclinical Work ongoing
Late 2022
Anticipating the threat of COVID-19 mutants and coronaviruses to public health we are uncovering prospects for the development of broad-spectrum therapeutics and vaccines.
